Brian Jahns
Corporate Officer/Principal bei GLOBAL HEALTH CLINICS LTD.
Aktive Positionen von Brian Jahns
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GLOBAL HEALTH CLINICS LTD. | Corporate Officer/Principal | 29.04.2021 | - |
Karriereverlauf von Brian Jahns
Ehemalige bekannte Positionen von Brian Jahns
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ENTHEON BIOMEDICAL CORP. | Corporate Officer/Principal | 01.03.2021 | 01.10.2022 |
TRILLIUM THERAPEUTICS | Corporate Officer/Principal | - | 31.12.2019 |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Vertrieb & Marketing | - | - |
Hoffmann-La Roche Ltd.
Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Ltd. is a Canadian pharmaceutical company that manufactures drugs. The company is based in Mississauga, Canada. | Corporate Officer/Principal | - | - |
Ausbildung von Brian Jahns
Wayne State University (Michigan) | Doctorate Degree |
Statistik
International
Kanada | 6 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GLOBAL HEALTH CLINICS LTD. | Health Services |
ENTHEON BIOMEDICAL CORP. | Health Technology |
Private Unternehmen | 3 |
---|---|
Trillium Therapeutics ULC
Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
Hoffmann-La Roche Ltd.
Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Ltd. is a Canadian pharmaceutical company that manufactures drugs. The company is based in Mississauga, Canada. | Health Technology |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Health Technology |
- Börse
- Insiders
- Brian Jahns
- Erfahrung